Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 349
Filtrar
1.
J Toxicol ; 2011: 503576, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22007212

RESUMEN

The biochemical transformation of mercury, tin, arsenic and bismuth through formation of volatile alkylated species performs a fundamental role in determining the environmental processing of these elements. While the toxicity of inorganic forms of most of these compounds are well documented (e.g., arsenic, mercury) and some of them are of relatively low toxicity (e.g., tin, bismuth), the more lipid-soluble organometals can be highly toxic. In the present study we investigated the cyto- and genotoxicity of five volatile metal(loid) compounds: trimethylbismuth, dimethylarsenic iodide, trimethylarsine, tetramethyltin, and dimethylmercury. As far as we know, this is the first study investigating the toxicity of volatile metal(loid) compounds in vitro. Our results showed that dimethylmercury was most toxic to all three used cell lines (CHO-9 cells, CaCo, Hep-G2) followed by dimethylarsenic iodide. Tetramethyltin was the least toxic compound; however, the toxicity was also dependend upon the cell type. Human colon cells (CaCo) were most susceptible to the toxicity of the volatile compounds compared to the other cell lines. We conclude from our study that volatile metal(loid) compounds can be toxic to mammalian cells already at very low concentrations but the toxicity depends upon the metal(loid) species and the exposed cell type.

2.
Environ Res ; 110(5): 435-42, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19758587

RESUMEN

Arsenic is a known human carcinogen, inducing tumors of the skin, urinary bladder, liver and lung. Inorganic arsenic, existing in highly toxic trivalent and significantly less toxic pentavalent forms, is methylated to mono- and di-methylated species mainly in the liver. Due to the low toxicity of pentavalent methylated species, methylation has been regarded as a detoxification process for many years; however, recent findings of a high toxicity of trivalent methylated species have indicated the contrary. In order to elucidate the role of speciation and methylation for the toxicity and carcinogenicity of arsenic, systematic studies were conducted comparing cellular uptake, subcellular distribution as well as toxic and genotoxic effects of organic and inorganic pentavalent and trivalent arsenic species in both non-methylating (urothelial cells and fibroblasts) and methylating cells (hepatocytes). The membrane permeability was found to be dependent upon both the arsenic species and the cell type. Uptake rates of trivalent methylated species were highest and exceeded those of their pentavalent counterparts by several orders of magnitude. Non-methylating cells (urothelial cells and fibroblasts) seem to accumulate higher amounts of arsenic within the cell than the methylating hepatocytes. Cellular uptake and extrusion seem to be faster in hepatocytes than in urothelial cells. The correlation of uptake with toxicity indicates a significant role of membrane permeability towards toxicity. Furthermore, cytotoxic effects are more distinct in hepatocytes. Differential centrifugation studies revealed that elevated concentrations of arsenic are present in the ribosomal fraction of urothelial cells and in nucleic and mitochondrial fractions of hepatic cells. Further studies are needed to define the implications of the observed enrichment of arsenic in specific cellular organelles for its carcinogenic activity. This review summarizes our recent research on cellular uptake, distribution and toxicity of arsenic compounds in methylating and non-methylating cells.


Asunto(s)
Arseniatos/metabolismo , Arsenitos/metabolismo , Carcinógenos/metabolismo , Compuestos de Sodio/metabolismo , Arseniatos/toxicidad , Arsenitos/toxicidad , Carcinógenos/toxicidad , Células Cultivadas , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Humanos , Espacio Intracelular/metabolismo , Metilación/efectos de los fármacos , Permeabilidad/efectos de los fármacos , Compuestos de Sodio/toxicidad , Pruebas de Toxicidad , Urotelio/efectos de los fármacos , Urotelio/metabolismo
3.
JAMA ; 286(15): 1869-78, 2001 Oct 17.
Artículo en Inglés | MEDLINE | ID: mdl-11597289

RESUMEN

CONTEXT: Activation of the coagulation system and depletion of endogenous anticoagulants are frequently found in patients with severe sepsis and septic shock. Diffuse microthrombus formation may induce organ dysfunction and lead to excess mortality in septic shock. Antithrombin III may provide protection from multiorgan failure and improve survival in severely ill patients. OBJECTIVE: To determine if high-dose antithrombin III (administered within 6 hours of onset) would provide a survival advantage in patients with severe sepsis and septic shock. DESIGN AND SETTING: Double-blind, placebo-controlled, multicenter phase 3 clinical trial in patients with severe sepsis (the KyberSept Trial) was conducted from March 1997 through January 2000. PATIENTS: A total of 2314 adult patients were randomized into 2 equal groups of 1157 to receive either intravenous antithrombin III (30 000 IU in total over 4 days) or a placebo (1% human albumin). MAIN OUTCOME MEASURE: All-cause mortality 28 days after initiation of study medication. RESULTS: Overall mortality at 28 days in the antithrombin III treatment group was 38.9% vs 38.7% in the placebo group (P =.94). Secondary end points, including mortality at 56 and 90 days and survival time in the intensive care unit, did not differ between the antithrombin III and placebo groups. In the subgroup of patients who did not receive concomitant heparin during the 4-day treatment phase (n = 698), the 28-day mortality was nonsignificantly lower in the antithrombin III group (37.8%) than in the placebo group (43.6%) (P =.08). This trend became significant after 90 days (n = 686; 44.9% for antithrombin III group vs 52.5% for placebo group; P =.03). In patients receiving antithrombin III and concomitant heparin, a significantly increased bleeding incidence was observed (23.8% for antithrombin III group vs 13.5% for placebo group; P<.001). CONCLUSIONS: High-dose antithrombin III therapy had no effect on 28-day all-cause mortality in adult patients with severe sepsis and septic shock when administered within 6 hours after the onset. High-dose antithrombin III was associated with an increased risk of hemorrhage when administered with heparin. There was some evidence to suggest a treatment benefit of antithrombin III in the subgroup of patients not receiving concomitant heparin.


Asunto(s)
Anticoagulantes/uso terapéutico , Antitrombina III/uso terapéutico , Insuficiencia Multiorgánica/etiología , Insuficiencia Multiorgánica/prevención & control , Inhibidores de Serina Proteinasa/uso terapéutico , Choque Séptico/complicaciones , Choque Séptico/tratamiento farmacológico , Adulto , Anticoagulantes/administración & dosificación , Antitrombina III/administración & dosificación , Método Doble Ciego , Interacciones Farmacológicas , Femenino , Heparina/uso terapéutico , Humanos , Masculino , Inhibidores de Serina Proteinasa/administración & dosificación , Análisis de Supervivencia , Síndrome de Respuesta Inflamatoria Sistémica/complicaciones , Síndrome de Respuesta Inflamatoria Sistémica/tratamiento farmacológico , Trombosis/etiología , Trombosis/prevención & control
4.
Arch Biochem Biophys ; 385(1): 28-40, 2001 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-11361022

RESUMEN

The predominant carotenoids of the macular pigment are lutein, zeaxanthin, and meso-zeaxanthin. The regular distribution pattern of these carotenoids within the human macula indicates that their deposition is actively controlled in this tissue. The chemical, structural, and optical characteristics of these carotenoids are described. Evidence for the presence of minor carotenoids in the retina is cited. Studies of the dietary intake and serum levels of the xanthophylls are discussed. Increased macular carotenoid levels result from supplementation of humans with lutein and zeaxanthin. A functional role for the macular pigment in protection against light-induced retinal damage and age-related macular degeneration is discussed. Prospects for future research in the study of macular pigment require new initiatives that will probe more accurately into the localization of these carotenoids in the retina, identify possible transport proteins and mechanisms, and prove the veracity of the photoprotection hypothesis for the macular pigments.


Asunto(s)
Luteína/química , Epitelio Pigmentado Ocular/química , Pigmentos Retinianos/química , beta Caroteno/química , Animales , Cantaxantina/metabolismo , Carotenoides/sangre , Cromatografía , Suplementos Dietéticos , Humanos , Luteína/sangre , Luteína/farmacología , Macaca , Modelos Químicos , Conformación Proteica , Retina/fisiología , Xantófilas , Zeaxantinas , beta Caroteno/análogos & derivados , beta Caroteno/farmacología
5.
Bioorg Med Chem Lett ; 11(11): 1379-82, 2001 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-11378359

RESUMEN

The serine protease urokinase plasminogen activator (uPA) is thought to play a central role in tumor metastasis and angiogenesis. Molecular modeling studies suggest that 5-thiomethylthiopheneamidine inhibits uPA by binding at the S1 pocket of the active site. Further structure based elaboration of this residue resulted in a novel class of potent and selective inhibitors of uPA.


Asunto(s)
Antimetabolitos/farmacología , Tiofenos/farmacología , Activador de Plasminógeno de Tipo Uroquinasa/antagonistas & inhibidores , Antimetabolitos/síntesis química , Antimetabolitos/química , Sitios de Unión , Humanos , Relación Estructura-Actividad , Tiofenos/síntesis química , Tiofenos/química , Activador de Plasminógeno de Tipo Uroquinasa/fisiología
6.
Bioorg Med Chem Lett ; 11(7): 915-8, 2001 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-11294390

RESUMEN

The serine protease urokinase (uPa) has been implicated in the progression of both breast and prostate cancer. Utilizing structure based design, the synthesis of a series of substituted 4-[2-amino-1,3-thiazolyl]-thiophene-2-carboxamidines is described. Further optimization of this series by substitution of the terminal amine yielded urokinase inhibitors with excellent activities.


Asunto(s)
Amidinas/síntesis química , Amidinas/farmacología , Activadores Plasminogénicos/antagonistas & inhibidores , Tiazoles/farmacología , Activador de Plasminógeno de Tipo Uroquinasa/antagonistas & inhibidores , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Relación Estructura-Actividad , Tiazoles/síntesis química , Tiofenos/síntesis química , Tiofenos/farmacología
7.
Invest Ophthalmol Vis Sci ; 42(1): 235-40, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11133874

RESUMEN

PURPOSE: To determine whether there is an association between the density of macular pigment in the human retina and the risk of age-related macular degeneration (AMD). METHODS: Retinas from 56 donors with AMD and 56 controls were cut into three concentric regions centered on the fovea. The inner, medial, and outer regions covered the visual angles 0 degrees to 5 degrees, 5 degrees to 19 degrees, and 19 degrees to 38 degrees, respectively. The amounts of lutein (L) and zeaxanthin (Z) extracted from each tissue sample were determined by high-performance liquid chromatography. RESULTS: L and Z levels in all three concentric regions were less, on average, for the AMD donors than for the controls. The differences decreased in magnitude from the inner to medial to outer regions. The lower levels found in the inner and medial regions for AMD donors may be attributable, in part, to the disease. Comparisons between AMD donors and controls using the outer (peripheral) region were considered more reliable. For this region, logistic regression analysis indicated that those in the highest quartile of L and Z level had an 82% lower risk for AMD compared with those in the lowest quartile (age- and sex-adjusted odds ratio = 0.18, 95% confidence interval = 0.05-0.64). CONCLUSIONS: The results are consistent with a theoretical model that proposes an inverse association between risk of AMD and the amounts of L and Z in the retina. The results are inconsistent with a model that attributes a loss of L and Z in the retina to the destructive effects of AMD.


Asunto(s)
Luteína/metabolismo , Degeneración Macular/metabolismo , Retina/metabolismo , Pigmentos Retinianos/metabolismo , beta Caroteno/análogos & derivados , beta Caroteno/metabolismo , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Donantes de Tejidos , Xantófilas , Zeaxantinas
8.
Vet Rec ; 147(15): 428, 2000 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-11072996
9.
Exp Eye Res ; 71(3): 239-45, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10973733

RESUMEN

Inverse associations have been reported between the incidence of advanced, neovascular, age-related macular degeneration (AMD) and the combined lutein (L) and zeaxanthin (Z) intake in the diet, and L and Z concentration in the blood serum. We suggest that persons with high levels of L and Z in either the diet or serum would probably have, in addition, relatively high densities of these carotenoids in the macula, the so-called 'macular pigment'. Several lines of evidence point to a potential protective effect by the macular pigment against AMD. In this study we examined the relationship between dietary intake of L and Z using a food frequency questionnaire; concentration of L and Z in the serum, determined by high-performance liquid chromatography, and macular pigment optical density, obtained by flicker photometry. Nineteen subjects participated. We also analysed the serum and retinas, as autopsy samples, from 23 tissue donors in order to obtain the concentration of L and Z in these tissues. The results reveal positive, though weak, associations between dietary intake of L and Z and serum concentration of L and Z, and between serum concentration of L and Z and macular pigment density. We estimate that approximately half of the variability in the subjects' serum concentration of L and Z can be explained by their dietary intake of L and Z, and about one third of the variability in their macular pigment density can be attributed to their serum concentration of L and Z. These results, together with the reported associations between risk of AMD and dietary and serum L and Z, support the hypothesis that low concentrations of macular pigment may be associated with an increased risk of AMD.


Asunto(s)
Dieta , Luteína/análisis , beta Caroteno/análogos & derivados , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Luteína/sangre , Degeneración Macular/sangre , Degeneración Macular/dietoterapia , Degeneración Macular/etiología , Masculino , Persona de Mediana Edad , Fotometría , Xantófilas , Zeaxantinas , beta Caroteno/análisis , beta Caroteno/sangre
10.
Bioorg Med Chem Lett ; 10(1): 1-4, 2000 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-10636229

RESUMEN

We describe a new class of potent, non-amide-based small molecule thrombin inhibitors in which an amidinohydrazone is used as a guanidine bioisostere on a non-peptide scaffold. Compound 4 exhibits nM inhibition of thrombin, is selective for thrombin, and shows 60 and 23% bioavailability in rabbits and dogs, respectively. Crystallographic analysis of 4 bound to thrombin confirmed the amindinohydrazone binding mode.


Asunto(s)
Amidinas/química , Amidinas/farmacología , Fibrinolíticos/química , Fibrinolíticos/farmacología , Guanidinas/química , Guanidinas/farmacología , Trombina/antagonistas & inhibidores , Administración Oral , Amidinas/síntesis química , Amidinas/farmacocinética , Animales , Sitios de Unión , Disponibilidad Biológica , Cristalografía por Rayos X , Perros , Fibrinolíticos/síntesis química , Fibrinolíticos/farmacocinética , Guanidinas/síntesis química , Guanidinas/farmacocinética , Cinética , Conejos , Inhibidores de Serina Proteinasa/farmacología , Relación Estructura-Actividad , Especificidad por Sustrato , Inhibidores de Tripsina/farmacología
11.
Bioorg Med Chem Lett ; 10(1): 79-82, 2000 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-10636249

RESUMEN

The structure activity relationships of a novel series of non-amide-based thrombin inhibitors are described. Exploration of the P2 and the aryl binding region for this series has identified optimal groups for achieving nanomolar potency. The binding modes of these optimal groups have been confirmed by X-ray structural analysis.


Asunto(s)
Antitrombinas/química , Antitrombinas/farmacología , Piperidinas/química , Piperidinas/farmacología , Trombina/antagonistas & inhibidores , Amidas/química , Arilsulfonatos/química , Arilsulfonatos/farmacología , Sitios de Unión , Cristalografía por Rayos X , Modelos Moleculares , Inhibidores de Serina Proteinasa/química , Inhibidores de Serina Proteinasa/clasificación , Inhibidores de Serina Proteinasa/farmacología , Relación Estructura-Actividad
12.
Bioorg Med Chem Lett ; 10(1): 83-5, 2000 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-10636250

RESUMEN

We expand the structural requirements and structure-activity relationship of a novel class of non-peptidic aryl-based thrombin inhibitors through exploration of the S1 specificity pocket of thrombin using flexible and constrained amidines. The most active compound of this class is 11 with Ki = 69 nM, which is ca. 15-fold less potent than constrained guanidine 5.


Asunto(s)
Amidinas/química , Antitrombinas/química , Antitrombinas/farmacología , Trombina/antagonistas & inhibidores , Amidinas/farmacología , Sitios de Unión , Hidrocarburos Aromáticos/química , Hidrocarburos Aromáticos/farmacología , Cinética , Conformación Proteica , Relación Estructura-Actividad , Especificidad por Sustrato , Trombina/química
13.
Crit Care Med ; 27(1): 66-72, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9934895

RESUMEN

OBJECTIVE: To obtain further insight into the constitutional, phenotype-dependent changes of T-helper-1 and T-helper-2 signature lymphokine synthesis after trauma. DESIGN: Prospective, descriptive study. SETTING: Intensive care unit of a burn center in a community hospital. PATIENTS: Ten patients 1, 3, 5, and 7 days after major burn injury and 15 healthy individuals. INTERVENTIONS: Peripheral blood mononuclear cells were separated and incubated (5 hrs) for cytokine production induced by the accessory cell-independent stimulus of ionomycin and phorbol 12-myristate 13-acetate. After fixation and permeabilization, cell samples were immunofluorescently stained for cell surface antigens (CD4 and CD8), intracellular interferon (IFN)-gamma, and interleukin (IL)-4 synthesis. Results were correlated with corresponding enzyme-linked immunosorbent assay measurements of the culture supernatants. MEASUREMENTS AND MAIN RESULTS: The phenotypic analysis of the composition of the helper (CD4) and suppressor/cytotoxic (CD8) T-cell subset demonstrated that patients suffering from major burns and healthy controls express these antigens in similar percentages. The ratio of CD4 positive to CD8 positive/CD16 negative T-cell subsets showed no significant changes after trauma compared with controls. The production of IL-4 was excessively up-regulated while the release of IFN-gamma was only slightly increased. The predominant cell source of IL-4 after burn trauma was the CD8+ cell with nearly five-fold increased production on day 5 (7.2+/-2.6%) vs. 1.5+/-0.4% in controls. While CD8+ cells are also capable of enhancing their IFN-gamma synthesis under stress by about 60% due to the significant participation of the naive CD45RA+ subset, the CD4+ IFN-gamma release remained largely unchanged. With this study, we demonstrated that in nonsurvivors the number of CD8+ IL-4-producing cells was significantly higher compared with controls; also, the number of IFN-gamma-releasing memory/effector CD45RO+ cells was lower compared with survivors. CONCLUSIONS: In previous experiments, we show that a shift to T(H)2 dominated phenotypes increases the risk for postburn infection. The current study confirms that major burns induce a significant shift of cytokine response in the T(H)2 direction and demonstrates that the CD8+, rather than the CD4+ phenotype, is present. Increased IL-4 production is associated with the T(H)2 lymphocyte. These diagnostic tests may help to differentiate patients with compensatory anti-inflammatory response syndrome and immunosuppression from those patients in the proinflammatory state associated with the systemic inflammatory response syndrome. The profile described in this article is associated with immunosuppression and may contraindicate attempts at anti-inflammatory therapy for sepsis.


Asunto(s)
Quemaduras/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/metabolismo , Tolerancia Inmunológica , Interferón gamma/metabolismo , Interleucina-4/metabolismo , Adulto , Anciano , Estudios de Casos y Controles , Cuidados Críticos/métodos , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Prospectivos
15.
Cell Biol Int ; 23(1): 61-72, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10755826

RESUMEN

Transforming growth factor beta-1 (TGF-beta1), which is present in lung tissue, has been suggested to play a role in modulating vascular cell function in vivo. The action of TGF-beta1 in vivo, especially at the local site of application to connective tissue, is anabolic and leads to pulmonary fibrosis and angiogenesis, strongly indicating that TGF-beta may have practical applications in repair of tissue injury caused by burns, trauma, or surgery. In the present study, we have used cultured bovine pulmonary artery endothelial (BPAE) cells as a model system. Expression of various proteins, including SPARC (secreted protein acidic and rich in cysteines), type IV procollagen and fibronectin (FN) was examined by radiolabeling the cells with [3H]proline, immunoprecipitation with specific antibodies, and Northern blot analyses by using specific cDNA probes. Cultured cells were labeled with [3H]proline for 24 h in either the absence or in the presence of TGF-beta1 (0-20 ng/ml). Incorporation of radioactivity was observed in a concentration-dependent manner, maximal at 5 ng/ml. Northern blot hybridization demonstrated that TGF-beta1 (5 ng/ml) treatment of BPAE cells caused an increase in steady-state levels


Asunto(s)
Endotelio Vascular/metabolismo , Proteínas de la Matriz Extracelular/biosíntesis , Factor de Crecimiento Transformador beta/farmacología , Animales , Northern Blotting , Bovinos , Células Cultivadas , Pulmón , ARN Mensajero/análisis
16.
Hum Factors ; 41(3): 467-73, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10665213

RESUMEN

A flight simulator and a computer-generated depiction of an environment with both natural and cultural features were used to teach and test navigation knowledge. Conditions of guided rehearsal, unguided rehearsal, and map study were used to familiarize participants with the navigation environment. A subsequent route-following test of navigation knowledge in the simulated environment showed that unguided rehearsal was better than map study or guided rehearsal for the development of route knowledge. In addition, a pointing task revealed that unguided mission rehearsal was as good as map study for the development of survey knowledge. Actual or potential applications of this research include the use of simulator-based mission rehearsal for military flight operations.


Asunto(s)
Aviación/educación , Interfaz Usuario-Computador , Adulto , Interpretación Estadística de Datos , Femenino , Humanos , Masculino , Mapas como Asunto , Análisis y Desempeño de Tareas , Percepción Visual
17.
J Med Chem ; 41(12): 2068-75, 1998 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-9622548

RESUMEN

The structure of the noncovalent complex of human alpha-thrombin with a nonpeptide inhibitor containing a central phenyl scaffold, N-[2-[5-methyl-3-(2-chlorophenylsulfonyloxy)phenoxy]ethyl]-N- methyl-4 -aminopyridine (1), has been determined to 2.20 A resolution. In addition, the thrombin-bound structures of two distinct amino acid-based inhibitors (3 and 4) containing different aminopyridine-derived guanidine mimetics have been determined. Each compound occupies the same region of the active site and projects an aminopyridine, a central hydrophobic group, and an aryl group, into the S1, S2, and aryl subsites on thrombin. Nonpeptide 1 forms only one direct intermolecular hydrogen bond to the thrombin active site and forms no hydrogen bonds to ordered molecules of solvent. Close contacts are observed between main-chain carbonyl groups on thrombin and the edges of the central phenyl and aminopyridine rings and the sulfonyl group of 1 such that atoms carrying opposite partial charges are juxtaposed. Aminopyridine groups in 3 and 4 also form close contacts with the edges of carbonyl groups on thrombin and are flexibly accommodated in the S1 subsite. Superposition of the bound conformations of 1 and D-Phe-Pro-amidobutylguanidine (2) revealed that the central phenyl scaffold of 1 substitutes for the peptide main chain of 2.


Asunto(s)
Aminopiridinas/química , Dipéptidos/química , Inhibidores Enzimáticos/química , Guanidinas/química , Imitación Molecular , Trombina/química , Aminopiridinas/metabolismo , Aminopiridinas/farmacología , Sitios de Unión , Cristalografía por Rayos X , Dipéptidos/metabolismo , Dipéptidos/farmacología , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/farmacología , Guanidinas/metabolismo , Guanidinas/farmacología , Humanos , Modelos Moleculares , Conformación Molecular , Conformación Proteica , Trombina/antagonistas & inhibidores , Trombina/metabolismo
19.
Bioorg Med Chem Lett ; 8(13): 1595-600, 1998 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-9873397

RESUMEN

We describe the in vitro evaluation and crystallographic analysis of a new class of potent and selective, non-amino acid-based, small-molecule thrombin inhibitors, exemplified by 14. This class of achiral inhibitors lacks an amide-based backbone, exhibits nM inhibition of thrombin, and is selective for thrombin. Compound 14 does not interact with the active-site catalytic apparatus and is anchored to the enzyme via a single network of hydrogen bonds to Asp189 of the S1 pocket.


Asunto(s)
Antitrombinas/farmacología , Amidas/química , Antitrombinas/química , Cristalografía , Evaluación de Medicamentos , Enlace de Hidrógeno , Estructura Molecular
20.
Curr Probl Diagn Radiol ; 26(6): 269-308, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9394868

RESUMEN

Pulmonary radiographs are essential adjuncts to the evaluation and diagnosis of suspected pulmonary disease. In the intensive care unit, radiographs are useful to confirm correct positioning of diagnostic and therapeutic devices. Patterns seen on the radiograph may be within broadly normal limits or may be interpreted as abnormal, especially when placed in the clinical context of a specific patient's problem. The description abnormal can be related to both nonspecific and specific radiographic patterns of disease. Nonspecific radiographic patterns of disease include location of disease, temporal course of disease, pleural abnormalities, hyperinflation, extra-alveolar air, atelectasis, bronchiectasis, and vascular disease. Specific radiographic patterns of disease are discrete anatomic structures seen on a radiograph, for example, cavitary and cystic disease. The interpretation of nonspecific and specific radiographic patterns is useful in diagnosis, selection of treatment, and monitoring of the course of disease and the patient's response to treatment.


Asunto(s)
Enfermedades Pulmonares/diagnóstico por imagen , Diagnóstico Diferencial , Humanos , Enfermedades Pulmonares/fisiopatología , Radiografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA